Quest Diagnostics
Quest Diagnostics Incorporated, a leading provider in the diagnostic testing industry, is headquartered in the United States. Founded in 1967, the company has established itself as a pivotal player in laboratory services, offering a comprehensive range of diagnostic information services that include clinical laboratory testing, anatomic pathology, and genetic testing. With a strong operational presence across North America, Quest Diagnostics is renowned for its commitment to innovation and quality, providing unique solutions that enhance patient care. The company has achieved significant milestones, including advancements in molecular diagnostics and a robust network of patient service centres. Recognised for its market leadership, Quest Diagnostics continues to set the standard in the healthcare sector, delivering reliable and accurate testing services that empower healthcare providers and patients alike.
DitchCarbon Score
How does Quest Diagnostics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Quest Diagnostics's score of 37 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Quest Diagnostics's reported carbon emissions
In 2022, Quest Diagnostics reported significant carbon emissions, totalling approximately 288,624,000 kg CO2e for Scope 1 and about 94,474,000 kg CO2e for Scope 2 emissions in the US. Globally, their emissions included about 107,228,000 kg CO2e for Scope 1 and approximately 91,613,000 kg CO2e for Scope 2, alongside a substantial Scope 3 total of around 820,410,000 kg CO2e. Quest Diagnostics has set ambitious climate commitments, aiming to reduce their Scope 1 and Scope 2 emissions by 30% from 2021 levels by the year 2030. This commitment reflects their proactive approach to addressing climate change and reducing their overall carbon footprint. The company is currently on track to meet these near-term reduction targets, demonstrating a strong commitment to sustainability within the healthcare sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 83,929,000 | 00,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 145,724,000 | 000,000,000 | 000,000,000 | 00,000,000 |
| Scope 3 | 41,299,000 | 00,000,000 | - | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Quest Diagnostics is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
